KEY POINTS
  • The pharmaceutical industry is being careful to not set any dangerous precedent that may weaken their future intellectual property rights, Milena Izmirlieva from IHS Markit said. 
  • The World Health Organization said 21 candidate vaccines are in clinical trials at the moment, meaning they are being tested on human volunteers.
  • Three of them are said to be in the third phase of those trials, according to the WHO. 

As the race to develop a vaccine for the coronavirus speeds up, the pharmaceutical industry is being careful to not set any dangerous precedent that may weaken their future intellectual property rights, a senior executive at IHS Markit said Thursday. 

The World Health Organization this week published an update on the potential vaccine candidates that are in development for Covid-19. Currently, 21 candidate vaccines are in clinical trials, meaning they are being tested on human volunteers. Three are reportedly in the third phase of those trials.